Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices 21243 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

[Transmittal No. 07–21] 

36(b)(1) Arms Sales Notification 

AGENCY: Department of Defense, Defense 

Security Cooperation Agency. 

ACTION: Notice. 

SUMMARY: The Department of Defense is 

publishing the unclassified text of a 

section 36(b)(1) arms sales notification. 

This is published to fulfill the 

requirements of section 155 of Public 

Law 104–164, dated 21 July 1996. 

FOR FURTHER INFORMATION CONTACT: Ms. 

J. Hurd, DSCA/DBO/CFM, (703) 604–

6575. 

The following is a copy of a letter to 

the Speaker of the House of 

Representatives, Transmittal 07–21 with 

attached transmittal and policy 

justification. 

Dated: April 24, 2007. 

L.M. Bynum, 

ODS Federal Register Liaison Officer, 

Department of Defense. 

BILLING CODE 5001–06–M 


rwilkins on PROD1PC63 with NOTICES
21244 Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices 


rwilkins on PROD1PC63 with NOTICESEN30AP07.014</GPH>
Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices 21245 


rwilkins on PROD1PC63 with NOTICESEN30AP07.015</GPH>
21246 Federal Register / Vol. 72, No. 82 / Monday, April 30, 2007 / Notices 

[FR Doc. 07–2098 Filed 4–27–07; 8:45 am] 

BILLING CODE 5001–06–C 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

Meeting of the Uniform Formulary 

Beneficiary Advisory Panel 

AGENCY: Department of Defense, 

Assistant Secretary of Defense (Health 

Affairs). 

ACTION: Notice of meeting. 

SUMMARY: This notice announces a 

meeting of the Uniform Formulary 

Beneficiary Advisory Panel. The panel 

will review and comment on 

recommendations made to the Director, 

TRICARE Management Activity, by the 

Pharmacy and Therapeutics Committee 

regarding the Uniform Formulary. The 

meeting will be open to the public. 

Seating is limited and will be provided 

only to the first 220 people signing in. 

All persons must sign in legibly. Notice 

of this meeting is required under the 

Federal Advisory Committee Act. 

DATES: Thursday, June 21, 2007, from 8 

a.m. to 4 p.m. 

ADDRESSES: Naval Heritage Center 

Theater, 701 Pennsylvania Avenue, 

NW., Washington, DC 20004 

FOR FURTHER INFORMATION CONTACT: 

Major Travis Watson, TRICARE 

Management Activity, Pharmaceutical 

Operations Directorate, Beneficiary 

Advisory Panel, Suite 810, 5111 

Leesburg Pike, Falls Church, VA 22041, 

telephone 703–681–2890, fax 703–681–

1940, or e-mail at 

baprequests@tma.osd.mil. 

SUPPLEMENTARY INFORMATION: The 

Uniform Formulary Beneficiary 

Advisory Panel will only review and 

comment on the development of the 

Uniform Formulary as reflected in the 

recommendations of the DOD Pharmacy 

and Therapeutics (P&T) Committee 

coming out of that body’s meeting in 

May 2007. The P&T Committee 

information and subject matter 

concerning drug classes reviewed for 

that meeting are available at http:// 

pec.ha.osd.mil. Any private citizen is 

permitted to file a written statement 

with the advisory panel. Statement must 

be submitted electronically to 

baprequests@tma.osd.mil no later than 

June 14, 2007. Any private citizen is 

permitted to speak at the Beneficiary 

Advisory Panel meeting, time 

permitting. One hour will be reserved 

for public comments, and speaking 

times will be assigned only to the first 

twelve citizens to sign up at the 

meeting, on a first-come, first-served 

basis. The amount of time allocated to 

a speaker will not exceed five minutes. 


rwilkins on PROD1PC63 with NOTICESEN30AP07.016</GPH>